NEWSROOM

AmpliTech Group Powers The Quantum Computing Revolution With Cutting-Edge Low-Noise Cryogenic HEMT Amplifiers

AmpliTech Group Powers The Quantum Computing Revolution With Cutting-Edge Low-Noise Cryogenic HEMT Amplifiers

HAUPPAUGE, N.Y., Dec. 11, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, proudly announces the successful development and deployment of its proprietary low-noise cryogenic High Electron...

read more
India’s First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way

India’s First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way

SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a significant achievement in surgical robotics SS Innovations reinforces India's position as a hub for technological innovation in healthcare using the SSi Mantra - Made in India, for the World The SSi Mantra integrates innovative advancements in robotic surgery, offering surgeons enhanced precision and...

read more
Blaqclouds, Inc. (OTC: BCDS) Completes Acquisition of ZEUS Blockchain Partners, Inc.

Blaqclouds, Inc. (OTC: BCDS) Completes Acquisition of ZEUS Blockchain Partners, Inc.

ROBESONIA, Pa., Dec. 10, 2024 - PRISM MediaWire - Blaqclouds, Inc. (OTC: BCDS) is pleased to announce the successful acquisition of ZEUS Blockchain Partners, Inc. ("ZEUS") from DMS Technology, Inc. This strategic acquisition solidifies Blaqclouds’ position as a leader in blockchain innovation while significantly expanding its footprint in the rapidly evolving decentralized technology sector. Under the terms of the agreement, Blaqclouds, Inc. acquired 100% of the issued and outstanding...

read more
EzFill Closes on the Purchase of Yoshi Mobility’s Fuel Division

EzFill Closes on the Purchase of Yoshi Mobility’s Fuel Division

--Company Adds 26 New Trucks to Growing Fleet-- --Begins Service in Four New States and Five New Markets-- Miami, FL, December 10, 2024 - PRISM MediaWire - EzFill Holdings Inc. (NASDAQ: EZFL), a leading mobile fueling company, has closed on the purchase of the mobile fueling division of Yoshi, Inc., expanding EzFill’s existing business into five new markets within four states. The transaction closed on Monday, December 2, 2024, and as a result EzFill has officially commenced operations in four...

read more
Universal Media Group Inc. (UMGP) wins Suncoast Emmy Award

Universal Media Group Inc. (UMGP) wins Suncoast Emmy Award

BOCA RATON, Fla., Dec. 10, 2024 - PRISM MediaWire - Universal Media Group Inc. (OTC: UMGP) is proud to announce that its Emmy-nominated weekly television show, Before The Fame with Mike Sherman, has won a prestigious Suncoast Emmy Award in the Long Form Content Editing category for its episode featuring pop superstar Shaggy. Page 27 https://youtu.be/Q-6jl0TrNSg This milestone marks a significant achievement for Scott Edward, Director of Editing at Universal Media Group, who has been nominated...

read more
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

January 13-16, 2025, San Francisco, CA IRVINE, Calif., December 9, 2024 - PRISM MediaWire - Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend “J.P. Morgan Week,” coinciding with the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, from January 13 - 16, 2025. During this period, Oncocyte will host one-on-one meetings with interested investors....

read more
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board

Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board

Klotho Neurosciences, Inc. continues to strengthen its advisory teams with recent new additions of Neuroscience and Big Pharma leaders to Scientific Advisory Board and Board of Directors New York, NY, December 9, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer’s and Parkinson’s disease is proud to announce the appointment of Dr. Merit Cudkowicz,...

read more
SKYX to Conduct a Company Presentation at Benchmark Conference on December 11, 2024, at 3:30pm

SKYX to Conduct a Company Presentation at Benchmark Conference on December 11, 2024, at 3:30pm

Rani Kohen, Founder, and Lenny Sokolow, Co-CEO of SKYX, to Present at 3:30 PM ET on December 11, 2024, and Engage in Investor Meetings Throughout the Conference at the New York Athletic Club MIAMI, December 9, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and over 60 lighting and home décor websites with a mission to make homes and...

read more
BranchOut Food Inc. Signs LOI and receives $250K PO from Leading Ingredient Distributor, Definitive Agreement Targeting $5-6M in 2025 Ingredient Sales

BranchOut Food Inc. Signs LOI and receives $250K PO from Leading Ingredient Distributor, Definitive Agreement Targeting $5-6M in 2025 Ingredient Sales

Projecting $4.0M in net revenue for Q1 2025—up 170% from the prior year—and expects to achieve positive cash flow in the same quarter Key Highlights: Signed LOI with leading ingredient distributor, establishing immediate sales volume in the ingredient channel. Received an initial $250,000 purchase order alongside the LOI. Anticipating completing a Definitive Agreement in January with a minimum commitment of $5M in sales for 2025. New Peru factory’s three production lines are now fully...

read more
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

IRVINE, Calif., Dec. 04, 2024 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI™ assay. In a paper recently published in the journal Acta Neuropathologica Communications, DetermaCNI showed promise as a liquid biopsy method for diagnosing and profiling central nervous system tumors by measuring somatic copy number aberrations (SCNAs) in cerebrospinal fluid. For context, copy number...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850